OMB Rule Guidance
Northeast
Currently listing programs from Beth Israel Deaconess Medical Center, Boston University, Brigham & Women's Hospital, Brown University, The Children's Hospital of Philadelphia, Columbia University, Harvard Medical School, Icahn School of Medicine at Mount Sinai, The Johns Hopkins University, University of Massachusetts, University of Pittsburgh, Schepens Eye Institute, Temple University and Yale University
Southeast
Project Leaders:
Jennifer S. Li
Email: li000001@mc.duke.edu
Svati H. Shah
Project Number: 1T32HL176430-01A1
https://scholars.duke.edu/grant/296092
Program Scope and Mission – There is an urgent need to expand the pipeline of highly trained scientists and physician-scientists equipped to advance research across the spectrum of pediatric and congenital heart disease. The Interdisciplinary Research Training Program for Pediatric & Congenital Heart Disease (iPediHeart) is designed to meet this need by providing post-doctoral research fellows with rigorous, individualized research mentorship, a custom-tailored curriculum, and direct engagement with multi-disciplinary research mentors. By cultivating the next generation of experts through intensive scientific training and cross-disciplinary collaboration, iPediHeart will strengthen the field and accelerate the discovery of innovative strategies to improve outcomes for individuals with pediatric and congenital heart disease.
Project Leaders:
Kanecia O. Zimmerman
email: kanecia.zimmerman@duke.edu
Ian J. David
email: ian_davis@med.unc.edu
Project Number: 2T32HD094671-06A1
Program Scope and Mission – The pipeline for novel therapeutics for children is extremely limited compared to that of adults due to several aspects of therapeutic development for the pediatric population, including specific safety, regulatory and ethical concerns, the low incidence of many pediatric diseases, and age-dependent pharmacokinetic factors. Therefore, there remains a paramount need for pediatric physician-scientists who are knowledgeable in pediatric drug discovery, clinical trial design, and postmarketing evaluation. This renewal application for the Unified Program for Therapeutics in Children (UPTiC) will continue to train pediatric physician-scientists to lead the development, implementation, and evaluation of novel prophylactics and therapeutics for pediatric populations to improve the health and well-being of children.
Project Leader:
Terry Lechler
email: terry.lechler@duke.edu
Project Number: 5T32HD040372-24
https://medschool.duke.edu/education/biomedical-phd-programs/developmental-stem-cell-biology-program
Program Scope and Mission – The Developmental & Stem Cell Biology (DSCB) Program provides innovative training for the next generation of scientists and fosters discoveries that improve an understanding of developmental diseases. This research may translate to treatments that improve human health, reduce illness, repair tissue damage and lengthen life.
Project Leaders:
Shannon L. Meeks
email: smeeks@emory.edu
Clinton H. Joiner
Project Number: 5T32HL139443-08
Program Scope and Mission – Research in hematology has yield important knowledge about fundamental biological processes and has improved the survival and quality of life for persons with blood diseases. Great strides have been made in the treatment of children with sickle cell disease, hemophilia, bone marrow failure and other blood disorders. Yet the number of well-trained researchers in this field is steadily declining, especially in pediatrics. This T32 Training Grant is designed to address this problem by providing high quality research training to highly motivated and talented post-doctoral MD, MD/PhD, and PhD researchers to enable them to become the next generation of physician scientists and translational investigators in pediatric non-malignant hematology.
Project Leaders:
Hanjoong Jo
email: hjo@emory.edu
John Oshinski
email: jnoshin@emory.edu
Project Number: 5T32HL166146-03
https://sites.gatech.edu/cbtemtech/
Program Scope and Mission – This interdisciplinary Program in Cardiovascular Biomechanics at Emory University and Georgia Tech (CBT@EmTech) will train the next generation of biomedical engineers to study how biomechanics affects cardiovascular diseases. Trainees will receive formal coursework, research training, and professional development that will enable them to apply an integration of engineering, vascular biology, data sciences, and biosciences to unsolved problems in cardiovascular medicine. We expect these trainees to be thought leaders in the diagnosis and treatment of cardiovascular disease.
Project Leaders:
John D. Roback
email: JROBACK@EMORY.EDU
Una O'Doherty
email: una.odoherty@emory.edu
Project Number: 2T32HL069769-21
Program Scope and Mission – Transfusion medicine represents an important specialty that provides blood components and cell therapies for clinical use. Future improvements and developments in this field will lead to safer and more effective therapies. This training program will produce many of the future leaders who will spearhead these advances in transfusion and related therapies.
Director and Contact:
W. Robert Taylor, MD, PhD
Division of Cardiology
Emory University School of Medicine
Email: W.robert.taylor@emory.edu
Program Scope and Mission – We are recruiting postdoctoral research trainees to work in the laboratories of investigators in the Division of Cardiology at Emory University School of Medicine. Several positions are available in basic science and translational laboratories within the Division. All projects involve animal and cell-based model systems to study vascular biology or cardiovascular disease. Trainees will be responsible for designing, conducting and presenting research, as well as participating in appropriate training, seminars and symposiums as required.
Successful candidates will have a strong publication record in peer reviewed journals and a long-term goal of becoming an independent investigator. Due to grant funding restrictions, candidates must meet the following two criteria to be considered: hold a MD, PhD or equivalent degree AND be a United States citizen or green card holder.
Director:
Dr. Donald Menick, Ph.D.
Director, Gazes Cardiac Research Institute
Professor of Medicine
Professor of Biochemistry & Molecular Biology
Director, Molecular & Cellular Biology & Pathology Program
Email: menickd@musc.edu
Contact:
Dr. Donald Menick, Ph.D.
Department of Medicine, Division of Cardiology
Medical University of South Carolina
Gazes Cardiac Research Institute
114 Doughty Street, Room 203
Charleston, SC 29403
Email: menickd@musc.edu
Website: http://academicdepartments.musc.edu/cardiotraining/
Program Scope and Mission – Research at the Medical University of South Carolina (MUSC) has rapidly developed over the past 25 years and cardiovascular biology has been a major focus of resource commitment. For FY2011 MUSC investigators received more than $12.7 million of research funding from the NHLBI alone. Since the beginning of this training program in 1977, there has been and continues to be a strong emphasis on the molecular and structural aspects of the entities involved in cellular dysfunction in cardiovascular disease. MUSC provides an exciting environment for creative, committed investigators and trainees interested in cardiovascular function in health and disease.
Postdoctoral and predoctoral positions are supported by the National Institute of Heart, Lung and Blood training grant "Training to Improve Cardiovascular Therapies". Our objective is the training of promising new scientists with backgrounds in physical, chemical and biomedical sciences in mechanisms of cardiovascular diseases and the experimental strategies and technologies necessary for the development of novel molecular therapeutics targeting these diseases. Our aim is to produce outstanding investigators with broad insight into cardiovascular biology and dysfunction capable of making significant contributions to cardiovascular research. Faculty in the training program come from five broad research areas: 1) Molecular basis of cardiovascular development, 2) Mechanisms of cardiovascular development, 3) Cardiac stem cells and regenerative medicine and bioengineering, 4) Cell signaling, and 5) Proteomics. Our faculty is highly interactive in both predoctoral and postdoctoral training, and our postdoctoral students benefit in many ways from an organized graduate program in cardiovascular biology.
Project Leader:
Carol Feghali-Bostwick
email: feghalib@musc.edu
Project Number: 5T32HL144470-07
Program Scope and Mission – There is an urgent, unmet public health need to improve outcomes for chronic lung diseases, which disproportionately impacts the Southeast. This program will provide research training for investigators who will ultimately improve the healthcare and outcomes for individuals with lung diseases with particular emphasis on lung cancer prevention, screening and implementation, critical care, telehealth, and rare lung diseases, including pulmonary fibrosis, sarcoidosis and cystic fibrosis. Training in innovation and entrepreneurship will enable investigators to create innovative solutions to challenges in health, to catalyze interdisciplinary entrepreneurial efforts, and ultimately become change agents to address national and global health problems.
Director:
Dr. Marie Davidian, Ph.D.
J. Stuart Hunter Distinguished Professor
Program Co-Director, NHLBI Integrated Biostatistical Training Program for CVD Research
Email: marie_davidian@ncsu.edu
Contact:
Dr. Marie Davidian
Department of Statistics
Email: davidian@ncsu.edu
Website: https://www.stat.ncsu.edu/programs/nhlbi/
Program Scope and Mission – The shortage of skilled biostatisticians equipped to address emerging challenges in this exciting new era of CVD research calls for training that formally integrates (i) in-depth experience in collaboration in a multidisciplinary environment, (ii) mastery of the theoretical underpinnings of statistics required for valid application of sophisticated biostatistical techniques and research on development of new methodology, and (iii) emphasis on communication and leadership skills. The program capitalizes on the long-standing partnership between NCSU and Duke, which provides trainees with the opportunity for outstanding theory and methods training and to work with internationally-known researchers at the forefront of CVD research. Trainees will develop all of these skills through interaction with faculty at both universities, who themselves have a history of inter-institutional collaboration and research and who have extensive experience in training and mentoring.
The training involves formal coursework in the student's home department on foundational statistical theory, including probability, inference, linear and other statistical models, measure theory and advanced probability, and advanced statistical inference; and on statistical methods, including clinical trial design/analysis, longitudinal data analysis, survival analysis, epidemiology, causal inference, machine learning, and high-dimensional data analysis; and exposure at DCRI to fundamental aspects of CVD medicine, working with large, complex biomedical data, and research responsibility and ethics considerations. There is also extensive formal and experiential training in communication and leadership skills at both institutions. Trainees are introduced to DCRI CVD research gradually and will evolve over their tenures to holding substantial collaborative apprenticeships in which they are fully integrated as functioning members of DCRI project teams. The apprenticeships will provide trainees with extensive working knowledge of CVD research, the opportunity to develop collaborative skills, and the recognition of how new biostatistical methods development follows from challenges encountered in the collaborative context. This last point will be emphasized through mechanisms under which statistical methodological challenges arising in trainees' apprenticeships will lead to doctoral dissertation research in biostatistics.
Project Leaders:
Ana-Maria Staicu
email: astaicu@ncsu.edu
Sean M. O'Brien
email: obrie027@mc.duke.edu
Project Number: 5T32HL079896-19
https://statistics.sciences.ncsu.edu/group/faculty/
Program Scope and Mission – Biostatisticians are key contributors to cardiovascular disease research, and demand continues to escalate for PhD biostatisticians with the required training, particularly in this era of biomedical big data. This program will provide predoctoral students at North Carolina State University and Duke University with unique training that integrates rigorous study of statistical theory and methods with a collaborative apprenticeship working on cutting edge cardiovascular disease research studies in multidisciplinary teams at the Duke Clinical Research Institute to prepare them to make immediate contributions to the cardiovascular disease research enterprise.
Director and Contact:
Martin E. Young, DPhil
Professor of Medicine
Jeanne V. Marks Endowed Chair of Cardiovascular Disease
Division of Cardiovascular Disease
Department of Medicine
Heersink School of Medicine
University of Alabama at Birmingham
martinyoung@uabmc.edu
Phone (205) 934-2328
https://www.uab.edu/hypertension/education/t32
Program Scope and Mission – Postdoctoral fellowships are available through the Vascular Biology and Hypertension Program at the University of Alabama at Birmingham (UAB), funded by the National Institutes of Health (NIH)/National Heart, Lung and Blood Institute (NHLBI) institutional training grant, T32 HL007457, “Mechanisms of Hypertension and Cardiovascular Diseases.” This T32 Training Program offers multidisciplinary training in fundamental aspects of the pathophysiology of hypertension and related cardiovascular disease, in innovative approaches to the diagnosis and treatment of these conditions and in translating basic and clinical research findings to the population level. The Program offers advanced training in the following thematic focus areas: Basic Science (fundamental training in mechanisms of inflammatory vascular injury and repair and oxidative stress/free radical injury); Translational Science (translation-to-humans, early clinical trials, testing basic science discoveries for clinical applicability) Clinical Science (research to improve knowledge of new therapies, medical applications and clinical interventions), and Population and Data Science (clinical trials to wide-spread evidence-based practice that improves the overall public health). A list of participating T32 faculty mentors and programs is available upon request.
Project Leader:
Amit Gaggar
email: agaggar@uab.edu
Project Number: 5T32HL105346-15
https://www.uab.edu/medicine/pulmonary/education/t32-training-grant
Program Scope and Mission – This Training Program in Lung Biology and Translational Medicine at the University of Alabama at Birmingham (UAB) is designed to train the next generation of biomedical scientists and physician-scientists with the application of innovative techniques/tools and approaches to address emerging public health concerns related to respiratory disease.
Project Leader:
William M. Geisler
email: wgeisler@uab.edu
Project Number: 5T35HL007473-42
https://www.uab.edu/medicine/surgery/education/medical-students/streams
Program Scope and Mission – Physician scientists play an important role in addressing the prevention and management of heart, lung, blood, and sleep disorders through research whose findings can advance the development of new diagnostic, treatment, and prevention strategies. The goal of this renewal proposal is to continue to provide medical students with skills and knowledge in translational research through mentored research experiences at the University of Alabama at Birmingham that are concentrated in heart, lung, and/or blood fields and through didactics. The impact of the program will be the development of highly motivated, well-trained, early physician scientists who are interested in and motivated for pursuing an academic medicine career involving heart, lung, and/or blood research.
Project Leader:
Barbara A. Gower
email: bgower@uab.edu
Project Number: 2T32HL105349-16
https://www.uab.edu/norc/join-us/become-a-trainee/pre-doc
Program Scope and Mission – Obesity is a highly prevalent condition that exacts a high price in suffering for afflicted individuals and economically for society. Causes are complex, manifold, and only partially understood, and available treatments are only modestly effective, impractical, or unrealistically expensive. New scientific insights are badly needed, and training a new generation of multidisciplinary obesity researchers is essential to meet that objective.
Director:
Jack M. Rogers, PhD
Professor, Department of Biomedical Engineering
Co-Director Jianyi Zhang, MD, PhD
Professor and Chair, Department of Biomedical Engineering
Contact:
Jack M. Rogers
Email: jrogers@uab.edu
Phone: 205-975-2102
University of Alabama at Birmingham
School of Medicine Dept. of Biomedical Engineering
Volker B128
1670 University Blvd
Birmingham, Alabama 35233
Program Scope and Mission – Cardiovascular tissue engineering (CVTE) has tremendous, but as yet unrealized, potential to treat disease. Future scientists and engineers working in this area will need expertise in a broad range of subfields including cardiovascular pathophysiology, cell/scaffold engineering methods, and the diverse technologies needed to evaluate the electromechanical safety and efficacy of prototype therapies. To help meet this need, the NIH National Institute of Biomedical Imaging and Bioengineering (NIBIB) has awarded UAB a new Ruth L. Kirschstein NRSA Institutional Research Training Grant (T32). The five year grant, titled “Development and Functional Assessment of Cardiovascular Tissue Engineering Therapy,” will be co-directed by BME Chair Jay Zhang and myself. The program will support up to four predoctoral students per year drawn from UAB’s Biomedical Engineering and Graduate Biomedical Sciences programs. The new program builds on research strengths in CVTE-related fields in the BME department and across UAB. We are excited and thankful for the new support from NIH and look forward to training a cadre of professionals in academia, government, and industry who will accelerate the safe clinical adoption of CVTE technology.
Project Leader:
Gordon S. Mitchell
email: gsmitche@phhp.ufl.edu
Project Number: 5T32HL134621-09
https://breathe.phhp.ufl.edu/training/uf/
Program Scope and Mission – Although diminished breathing capacity and airway defense undermine the quality and duration of life in virtually all neuromuscular disorders, such as spinal injury, ALS, Pompe disease, muscular dystrophy and Parkinson’s disease, few biomedical researchers have the expertise and translational perspective needed to develop new treatments that preserve or restore the ability to breathe and defend the airway. This renewal application seeks continued funding to train pre- and postdoctoral fellows with basic science, clinical or engineering backgrounds to fill this critical need. Trainees will develop a solid foundation in the respiratory biology, airway defense, translational research and technical/analytical skills needed for productive careers in breathing research and therapeutics.
Project Leaders:
Gilbert Rivers Upchurch
email: gib.upchurch@surgery.ufl.edu
Scott Berceli
email: bercesa@surgery.ufl.edu
Project Number: 5T32HL160491-04
https://surgery.med.ufl.edu/research/surgical-resident-research/ufvascularsurgeryt32/
Program Scope and Mission – A decline in the number of physician-scientists will impact our nation’s capacity to produce innovative research for patients with vascular disease. Attracting the brightest minds into an academic research career is critical. This project creates a 2-year integrated training program for surgery residents and fellows to develop a career pathway for conducting mechanistic and clinically relevant translational research in vascular disease.
Project Leaders:
Scott Berceli
email: bercesa@surgery.ufl.edu
Robert Maile
email: robert.maile@surgery.ufl.edu
Project Number: 5T35HL007489-42
Program Scope and Mission – The purpose of this T35 grant renewal is to provide intensive, short-term (10-week) research training for 20 medical students who will conduct clinical, translational, and basic research projects relevant to the mission of the National Heart, Lung, and Blood Institute. The research will be conducted under the mentorship of faculty members from the Colleges of Medicine and Engineering, who have a proven record of mentoring. The program is designed to attract the most highly qualified University of Florida medical students into careers as physician- scientists in the fields of cardiovascular and pulmonary research.
Project Leader:
Joey P. Granger
email: jgranger@umc.edu
Project Number: 2T32HL105324-16
Program Scope and Mission – Hypertension has long been recognized as a major risk factor for cardiovascular diseases, including coronary artery disease, heart failure and stroke, and for ESRD. In the southeastern United States, and especially in Mississippi, cardiovascular and renal diseases occur much more frequently than in the rest of the country. The objective of the multidisciplinary Hypertension and Cardiorenal Diseases Research (HCDR) Training Program is to recruit, train, and mentor pre-doctoral and postdoctoral students in cardiovascular and renal research so that they become the next generation of researchers in this field.
Project Leaders:
Claire M. Doerschuk
email: cmd@med.unc.edu
Richard Charles Boucher
email: RBOUCHER@MED.UNC.EDU
Project Number: 5T32HL166141-03
https://www.med.unc.edu/medicine/pulmonary/training/
Program Scope and Mission – Our Program will provide M.D., M.D./Ph.D. and Ph.D. post-doctoral fellows with state-of-the-art research training in common and rare lung diseases affecting the pediatric and adult populations. Lung diseases such as lung infections including bacterial and viral pneumonia, acute respiratory distress syndrome, genetic diseases of the airways including cystic fibrosis and primary ciliary dyskinesia, chronic obstructive pulmonary disease, asthma, environmental lung diseases, and lung diseases with an environmental component such as allergic lung diseases are common and are associated with devastating morbidity, mortality and use of health care dollars. Our Program offers 48 highly qualified faculty in 7 departments to serve as mentors and co-mentors for our trainees and provides a highly multidisciplinary pulmonary scientific community that creates an outstanding opportunity for trainees to develop their technical and intellectual abilities as scientists and to become independent investigators within the national community, pursuing important questions about the pathogenesis and course of lung diseases in pediatric and adult populations and developing novel therapies.
Project Leader:
Nigel S. Key
email: nigel_key@med.unc.edu
Project Number: 5T32HL007149-49
https://www.med.unc.edu/medicine/hematology/our-team/
Program Scope and Mission – This is a competitive renewal application for years 46-50 of a T32 program to train postdoctoral investigators in basic and translational benign hematology research. Our program’s primary goal is to develop future academic and scientific leaders in benign hematology research by training promising MD, PhD (or other similar degree) postdoctoral scientists to become independent laboratory-based and translational investigators focused on clinically relevant non-malignant hematology research topics. Highly qualified applicants will undergo comprehensive interdisciplinary research training and career development that prepares them well for sustained, impactful independent research careers.
Project Leader:
Christopher P. Mack
email: cmack@med.unc.edu
Project Number: 5T32HL069768-24
Program Scope and Mission – The Integrative Vascular Biology Program was established in 2002 to provide the next generation of scientists with the interdisciplinary and collaborative skills necessary to uncover the mechanisms by which genetic variation and environmental factors influence cardiovascular development and disease. Centered around UNC's McAllister Heart Institute, our 42 well-established, well-funded, and highly diverse faculty will provide state-of- the-art research training as part of a Program that requires trainees to collaborate with secondary mentors outside of their major area of interest. When combined with a well-developed academic program in Cardiovascular Science, well-developed research infrastructure at UNC, and a large pool of well-qualified applicants, our Program offers an outstanding environment for multidisciplinary pre-doctoral training.
Project Leaders:
Michelle Meyer
email: michelle_meyer@med.unc.edu
Jane Brice
Project Number: 5T35HL134624-08
https://www.med.unc.edu/emergmed/education/medical-students/istem/
Program Scope and Mission – The University of North Carolina at Chapel Hill Intensive Summer Research Training in Emergency Medicine (ISTEM) program will allow eight medical students per year to experience public health and medical research first-hand in topics related to emergency medicine and patient care of the heart, lungs, and blood. This program will provide the opportunity to gain relevant experience and insight into the research field directly under well-published, grant-funded mentors while maintaining strict guidelines and expectations. The value of this program will be immeasurable as ISTEM will influence the future direction of upcoming physician researchers early in their academic career.
Project Leader:
Wayne D. Rosamond
email: Wayne_Rosamond@unc.edu
Project Number: 5T32HL007055-49
https://bbsp.unc.edu/resources-policies/training-grants/
Program Scope and Mission – By continuing to innovate in active learning, engaged mentoring, dynamic research areas, and ongoing self-assessment the Cardiovascular (CV) Epidemiology Training Program at the University of North Carolina seeks to train effective and independent researchers in the disciplines and methods intersecting CV epidemiology. The proposed plan builds on historical strengths of the program and introduces new initiatives to strengthen the training experience. The program's trainees and alumni are exceptionally productive and successful researchers and scholars making important contributions to the field.
Contact:
Kari North, PhD
Professor and Program Director
Department of Epidemiology
University of North Carolina
137 East franklin Street Suite 306
CB# 7435
Chapel Hill, NC 27599
(919)966-2148
Kari_north@unc.edu
Website: https://sph.unc.edu/epid/epidemiology-research/genetic-epidemiology-research/
Program Scope and Mission – Human genome studies are providing fresh insights into heart, lung, and blood (HLB) traits, with opportunities for translation of research findings to clinical and community settings for disease prevention and health promotion. Yet, there remain an insufficient number of HLB genetic epidemiologists who can design and implement multidisciplinary HLB genetic epidemiology research that combines technological advances in genome measurement with cutting-edge statistical tools to advance understanding of the genomic basis of HLB traits and associated diseases in the most-burdened populations.
The Genetic Epidemiology of Heart, Lung, and Blood Traits (or GenHLB) Training Grant responds to these research gaps by providing interdisciplinary, integrated, and comprehensive instruction in the genetic epidemiology of HLB traits from an outstanding team of research mentors with expertise spanning four proposed training dimensions: HLB genetic epidemiology; computation/methods; `OMICs; and culture, diversity, and disparities. The Training Program will encompass formal didactics based on an individual development plan; tailored mentorship; research experiences in two training dimensions; presentations; manuscript and grant preparation; research seminars and colloquia; and instruction in the responsible conduct of research. The GenHLB training program also will include careful evaluation of the quality and effectiveness of the Training Program, ensuring that fellows achieve the competencies and skills necessary for success as future HLB genetic epidemiology research leaders.
The five-year program aims to support four (two pre-doctoral and two postdoctoral) fellows at initiation, increasing to six (three pre-doctoral and three postdoctoral) fellows in year 03. Among the postdoctoral fellows, prior expertise in epidemiology, human genetics, biostatistics, bioinformatics, computational biology, medicine, and applied mathematics will be sought. Pre-doctoral fellows will be required to pursue a doctoral degree in epidemiology, specializing in HLB genetic epidemiology. Our selection of internationally known research mentors with established research collaborations, unique and multidisciplinary training environment, and unparalleled research opportunities make us exceptionally well-positioned to lead this novel training program and develop the next generation of genetic epidemiology leaders who are well-equipped to investigate the genetic underpinnings of HLB traits and associated diseases.
Project Leader:
Sarah Y. Yuan
email: syuan@usf.edu
Project Number: 5T32HL160529-05
https://health.usf.edu/medicine/mpp/t32-program
Program Scope and Mission – Vascular inflammation plays a central role in a variety of cardiopulmonary diseases and organ injuries involving the brain, nerves, kidney, gut and placenta. Tremendous gaps of knowledge exist with regard to the cellular and molecular basis of inflammatory injury and its related organ-based pathophysiology, contributing to the hampered development of effective diagnostics and therapeutics. This program recruits a collaborative team of nationally recognized experts in inflammation research who will provide comprehensive training of our next generation of scientists in understanding and solving the complex problems beyond the scope of individual laboratories.
Director:
Dr. Kytai T. Nguyen
Contact:
The University of Texas at Arlington
Science & Engineering Innovation & Research Building, SEIR-367
655 W. Mitchell St.
Arlington, TX 76010
Phone: 817-272-2540
Website: https://blog.uta.edu/knguyen/
Program Scope and Mission – Nanotechnology and nanomedicine have been developed and used to detect and improve the treatment efficacy for many diseases, including cardiovascular and lung disorders. However, only a few doctoral programs exist to train doctoral (Ph.D.) students to have a background of strong, basic health and translational science in conjunction with new advances in nanotechnology and nanomedicine applied to cardiovascular and lung diseases. To bridge the gap, our long-term objective of this NIH T32 training program is to train doctoral students in North Texas in the principles, advances, opportunities and limitations of nanomaterials, nanomedicine and nanotechnology for use in the detection and treatment of cardiovascular and lung diseases. To reach our objective, we will provide an integrative nanotechnology training program, enhance trainees’ expertise and knowledge in broad-based nanotechnology areas, and achieve outstanding program outcomes in order to raise up the next generation of nanotechnology leaders.
Co-Directors:
Lance Terada, MD
Professor and Chief
Pulmonary and Critical Care
Philip Shaul, MD
Vice Chair for Research
Professor and Chief
Pulmonary and Vascular Biology
Contact:
Lance Terada, MD
Lance.terada@utsouthwestern.edu
Websites: http://www.utsouthwestern.edu/education/medical-school/departments/internal-medicine/divisions/pulmonary-critical-care/fellowships/fellowship-tracks.html
Program Scope and Mission – This program provides structured research training opportunities at the postdoctoral level with support for two years of training. The proposal is born out of a collaborative effort between divisions within the Pediatric and Internal Medicine departments involved in lung and vascular research at this institute, and is thus interdepartmental at its core. Our training faculty consist of experienced investigators representing 16 different clinical and basic science departments and centers, forming a solid, diverse training force, organized into four thematic tracks: 1) Pulmonary vascular disease; 2) Interstitial lung diseases; 3) Lung epithelial cell and differentiation disorders; and 4) Immunity/Inflammation/Sepsis. Besides mentor-based teaching, trainees will receive a comprehensive track- and project-specific didactic curriculum. Both clinical and basic science trainees will be guided by an individualized advisory committee that has both basic and clinical science mentors, to broaden the trainee’s perspective and facilitate bench to bedside thinking. Emphasis will be placed on maintenance of project focus, creative experimental design, state of the art technology, and careful early career guidance.
Project Leader:
Jonathan Lindner
email: jlindner@virginia.edu
Project Number: 5T32EB003841-20
Program Scope and Mission – Nearly one in 3 deaths in the U.S. is due to cardiovascular disease, most due to coronary heart disease. The need for improved noninvasive methods to detect early disease and to help manage chronic disease has never been as critical. Training academic clinician investigators in the physics, engineering, and translational research approaches to cardiovascular imaging is essential to future improvements.
Project Leaders:
Brant Isakson
email: BEI6N@VIRGINIA.EDU
Gary K. Owens
email: gko@virginia.edu
Project Number: 5T32HL007284-49
https://www.cvrc.virginia.edu/cardiovascular-training-program/
Program Scope and Mission – In spite of decades of research and expenditure of billions of dollars, cardiovascular disease (CVD) remains the leading cause of death worldwide and is increasing in incidence as a consequence of global Westernization with subsequent epidemics in obesity, metabolic disease, and diabetes, all of which greatly exacerbate CVD. A central premise of this Basic and Translational Cardiovascular Research Training Program (CVTP) is that these diseases are extremely complex, and that rigorous study of them requires trainees to have a strong foundation of knowledge in basic CV physiology, developmental biology, genetics, genomics, bioinformatics, epigenetics, pathology, systems biology, biomedical engineering, and many other disciplines. The goal of this training program is to provide both pre- and post-doctoral trainees a highly integrated training experience to enable them to be facile in all of these disciplines thus uniquely enabling them to conduct pioneering studies of the pathogenesis of CVD, and to contribute to development of innovative and much more effective ways to treat or prevent them.
Director:
Irving L. Kron, M.D.
Professor and Chair of Surgery
Division of Thoracic and Cardiovascular Surgery
Email: ilk@virginia.edu
Website:https://surgery.virginia.edu/tcv-lab/teaching-training/resident-research-training-program/
Contact:
Tony Herring, Laboratory Manager
P.O. Box 801359
Bldg MR4, Rm 3116
409 Lane Road
Charlottesville, VA 22908
Office: 434-924-9297 Fax: 434-924-1218
Email: ajh@virginia.edu
or
Victor E. Laubach, PhD
Professor of Surgery
Office: 434-924-2927 Fax: 434-924-1218
Email: laubach@virginia.edu
https://uvahealth.com/findadoctor/profile/irving-l-kron
Program Scope and Mission – Our TCV Surgery Research Training Program has been continuously funded since 2000 by an NIH T32 Training award with Dr. Irving Kron as the Principle Investigator. This training program provides collaboration between basic scientists and surgical faculty to train academic cardiothoracic surgeons. The main objective of our program is to provide surgery residents with hypothesis-driven research training in laboratory or clinical research in order to foster their development into independent academic translational researchers. Translational research defines the area of overlap between basic and clinical studies, where new therapies, interventions, assays, etc. are brought out of the laboratory for human benefit. The primary discipline which our program focuses on is translational research into vascular and end-organ function following transplantation or surgery.
Director:
Christopher M. Kramer, M.D.
Ruth C. Heede Professor in Cardiology
Director, Cardiovascular Imaging Center
Email: ckramer@virginia.edu
Website:https://med.virginia.edu/faculty/faculty-listing/cmk2n/
Contact:
Lisa Mackey
Cardiovascular Imaging Fellowship Coordinator
UVA Division of Cardiovascular Medicine
1215 Lee Street, Room 2772
PO Box 800662
Charlottesville, VA 22908
Email: lmm7x@virginia.edu
https://med.virginia.edu/cardiovascular-medicine/fellowship-education/advanced-fellowships-in-cardiovascular-medicine/cardiovascular-imaging/
Program Scope and Mission – UVA’s advanced fellowship in cardiovascular imaging trains fellows in the use of cutting-edge technology that in turn facilitates a better understanding of the mechanisms of heart disease and of cardiac physiology and pathophysiology.
Specific program goals include:
- providing competence in technical aspects of imaging;
- providing competence in cardiac physiology and pathophysiology;
- studying and developing innovative methods of imaging The Advanced Cardiovascular Imaging Fellowship Program is supported by a training grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB).
Project Leaders:
Leonard Bacharier
email: leonard.bacharier@vumc.org
Prince Joseph Kannankeril
email: prince.kannankeril@vumc.org
Project Number: 1T32HL176443-01A1
https://pediatrics.vumc.org/T32
Program Scope and Mission – The goal of this application is to create a new T32 program, Pediatric Cardiorespiratory Research Training Program: Childhood origins of diseases across the lifespan, allowing for identification and engagement of those pediatric fellows and PhD scientists with the aptitude and passion to develop as scientists through this mentored training program. We will focus on research themes in which the Vanderbilt Department of Pediatrics has internationally recognized programs of discovery combined with a record of sustained excellence in research mentorship. Each T32 fellow Investigator will have an individualized training program developed by the mentor and Training Directors in collaboration with a multidisciplinary scientific oversight team, with the option of completing a Masters research degree (MSCI, MPH, or MSACI), and will be supported by a broad array of institutional and departmental resources with the expectation that graduates will transition to well- established long-term scientist career development programs at Vanderbilt or other research intensive institutions.
Project Leader:
Lorraine Ware
email: lorraine.ware@vumc.org
Project Number: 5T32HL087738-20
https://medicine.vumc.org/divisions/allergy-pulmonary-critical-care-medicine/education/t32
Program Scope and Mission – It has never been more important to create and maintain a cadre of PhD and physician-scientists engaged in translational research in lung disease and critical illness. Given the unprecedented developments at the cellular and molecular level, including knowledge of the human genome, we are now poised for unprecedented progress in translation of this new knowledge base to the study of the pathophysiology, prevention and treatment of human disease. Investment and innovation in the training and career development of this class of new investigators is greatly needed and will prepare future researchers for the unique challenges associated with advancing science and public health in the realm of pulmonary and critical care medicine.
Project Leader:
Ray Stokes Peebles
email: stokes.peebles@vanderbilt.edu
Project Number: 5T32HL094296-18
https://medicine.vumc.org/divisions/allergy-pulmonary-critical-care-medicine/education/t32
Program Scope and Mission – While there are unprecedented opportunities for advancement in understanding of the fundamental mechanisms of lung diseases, the pipeline of new investigators who are trained and committed to careers in lung disease-oriented biomedical research is inadequate. This interdisciplinary training program is designed to meet this challenge by preparing future leaders in lung research to advance science and improve respiratory health.
Project Leaders:
Ravi Shah
email: ravi.shah@vumc.org
Quinn Stanton Wells
email: quinn.s.wells@vumc.org
Project Number: 5T32HL170965-02
https://medicine.vumc.org/divisions/cardiovascular-medicine/education/vucm-t32
Program Scope and Mission – The Vanderbilt University Cardiovascular Medicine T32 (VUCM-T32) aims to train the next generation of cardiovascular scientists and mentors with expertise in adult heart and vascular disease. Post-doctoral trainees will make discoveries during and after their training that will improve our understanding of heart and vascular disease and lead to new treatments, approaches to screening, and mechanisms.
Project Leaders:
Michael J. Ward
email: michael.j.ward@vumc.org
Alan Storrow
email: alan.storrow@vumc.org
Project Number: 5T32HL170986-02
https://emergencymedicine.vumc.org/research/vista-t32
Program Scope and Mission – Emergency medicine and hospital medicine are the foundation of hospital-based care for acute heart, lung, and blood disorders yet are underrepresented in scientific career development efforts. Drawing on institutional strengths in research training, scientific career development, and learning health systems, we propose the Vanderbilt Interdisciplinary Hospital-based Systems of Care Research Training Program (VISTA) for postdoctoral fellows. To improve hospital-based care in NHLBI priority areas, VISTA will provide rigorous mentored research training in discovery, evidence translation, data science, policy and epidemiology, and operations research, incorporating stakeholder engagement and health equity throughout the program.
Director:
Dr. C. Michael Stein, M.B., Ch.B.
Dan May Professor of Medicine and Pharmacology
Email: michael.stein@vanderbilt.edu
Website: https://wag.app.vanderbilt.edu/PublicPage/Faculty/Details/29060
Contact:
C. Michael Stein, M.B., Ch.B.
542 Robinson Research Building
Email: michael.stein@vanderbilt.edu
Website: https://medicine.mc.vanderbilt.edu/vanderbilt-clinical-pharmacology-fellowship-program-0
Program Scope and Mission – Vanderbilt’s Clinical Pharmacology Fellowship Program is a highly successful program that has produced graduates who are now in prominent positions in academia, industry and regulatory agencies. Our training program is registered with the American Board of Clinical Pharmacology and thus trainees are eligible to sit for the board exam.
The training period is at least 2 years, preferably more, and is weighted towards learning through mentored research. In addition, formal coursework and directed learning provide education in core skills. Trainees include individuals with an M.D., Ph.D. or Pharm.D. degree who are planning a career in clinical pharmacology or a career that will be strengthened by significant exposure to clinical pharmacology. A large and diverse faculty in the division, the rich resources at Vanderbilt and our commitment to training has established the outstanding reputation of this Clinical Pharmacology Fellowship Program. Continued excellence of the program depends on our fellows and we invest heavily in their training.
Project Leaders:
William Gregory Hundley
email: greg.hundley@vcuhealth.org
Lauren Ashley Cowart
email: lauren.cowart@vcuhealth.org
Project Number: 2T32HL149645-06A1
https://intmed.vcu.edu/divisions/cardiology/education/
Program Scope and Mission – There is a shortage of MD and PhD scientific researchers trained to develop new treatments for cardiovascular disease, the most common cause of death worldwide. Over the last 15 years, Virginia Commonwealth University, through the Pauley Heart Center, has created a high-quality cardiovascular (CV) research environment with federally funded, multi-disciplinary (14 institutional departments), translational (involving pursuit of fundamental discoveries that impact meaningful health outcomes) research projects conducive to training and mentoring young investigators. In this first renewal of our T32, we propose to train pre- and post-doctoral professionals and clinician scientists who desire an academic career in translational CV research; and to train mentors, mentors- in-training, and leaders-in-training, to help address the shortage of well-trained multi-disciplinary translational academic investigators in this area of high public health impact.
Project Leader:
David Herrington
email: david.herrington@advocatehealth.org
Project Number: 2T32HL076132-21A1
Program Scope and Mission – The need for cardiovascular disease training programs focused on clinical and population research is more compelling than ever. This training program, now in its 20th year, is specifically designed for clinical investigators seeking to apply state-of-the-art clinical and population research methods to important cardiovascular research questions. Such clinical investigators are urgently needed to address important aspects of our nation’s cardiovascular research agenda.
Contact:
Randi Sullivan, MD, MHS
Administrative Secretary
Wake Forest University School of Medicine
Department of Internal Medicine
Section on Cardiovascular Medicine
Medical Center Boulevard
Winston-Salem, NC 27157
Phone: 336.716.9124
Fax: 336.716.9188
randi.sullivan@wakehealth.edu
Program Scope and Mission – The purpose of the CVD Epidemiology Training Program, a federally-funded National Research Service Award (NRSA) Institutional Research Training Grant (2 T32 HL076132), is to attract and train a cohort of outstanding physician scientists who will be fluent in the latest developments in cardiovascular disease and able to apply this knowledge to the conduct of new cardiovascular epidemiology and clinical cardiovascular research. Key features of the training program include completion of a Master’s Degree in Clinical and Population Translational Science with a curriculum that also includes formal training in molecular biology and genetics, supplemental training in genomics, proteomics and informatics, joint mentorship with both clinical and basic science faculty, and participation in external NHLBI sponsored short courses in cardiovascular epidemiology, and the genetics of complex heart, lung, and blood disorders.
Simply send a description of your program to sharon@navbo.org. Include contact information and links to your web site.
Midwest
Director:
Karin Hoffmeister, M.D.
Senior Investigator Blood Research Institute
Professor of Biochemistry at Medical College of Wisconsin
Associate Professor of Pediatrics, Harvard Medical School
Email: K12Admin@bcw.edu
Contact:
Christina Daniels
K12 Program Administrator
BloodCenter of Wisconsin
Blood Research Institute
8733 W. Watertown Plank Rd.
Wauwatosa, WI 53226
Phone: (414) 937-6896
Email: Christina.Daniels@BCW.EDU
Website: https://www.translationalglycomics.com
Program Scope and Mission – Translational medicine fosters cross-functional collaborations between researchers and clinicians to facilitate new and precision-driven treatments for individualized therapy. While scientists and clinicians successfully applied this approach to four fundamental building blocks of life (nucleic acids, lipids, proteins and carbohydrates), the science of glycans (carbohydrates) has received the least attention. The diverse functions of glycans contribute to the structural integrity of biomolecules, extracellular matrix formation, signal transduction, protein folding, information exchange between cells, and host-pathogen interactions. Despite their functional diversity and specificity, carbohydrates are commonly associated with weight gain and diabetes while their major contributions to health and disease remain vastly understudied. Furthermore, the use and modulation of glycans has been largely unexplored in therapeutic strategies. There is an urgent need to support and educate glycoscientists concomitantly with the biology of human health and disease, thus enabling clinicians and glycoscientists to recognize medical needs and therapeutic opportunities. To meet these needs, the National Heart, Lung, and Blood Institute (NHLBI) for the first time has offered a K12 Career Development Program in translational glycosciences titled “National Career Development Consortium for Excellence in Glycosciences.”
One of the four national sites is the Blood Research Institute and the Center for Translational Glycomics, BloodCenter of Wisconsin (BCW), in association with the Medical College of Wisconsin (MCW), Roswell Park Comprehensive Cancer Center (Roswell), and Virginia Commonwealth University (VCU). This program, The Medical and Translational GlycOmics Program (Translational GlycO Program), is a multi-institution (Wisconsin, New York and Virginia) program, linking unique and diverse glycoscience expertise with research facilities, major teaching hospitals, blood banking and pharmaceutical education. It is expected that the Translational GlycO Scholars will commit to and pursue a glycoscience based investigation, as it relates to the mission of the NHLBI (heart, blood, lung, and sleep disorders). Training in investigative glycoscience thought processes and experimental tools will be provided through a rigorous program involving hands-on research, didactic coursework, collaboration with experienced scientists in and outside the field, dissemination of knowledge, paper and grant writing activities, and participation in the national K12 consortium. Scholars will become knowledgeable in 1) molecular aspects of glycoscience; 2) experimental research inquiries into functions of glycans; 3) translation of bench research to the bedside; 4) dissemination of research to scientists and the lay public; and 4) writing extramurally funded grant applications. For more information and application processes refer to the K12 Program Website
Director:
Ivor Benjamin, M.D., F.A.H.A., F.A.C.C.
Director, Cardiovascular Center
Professor, Department of Medicine
Froedtert & Medical College of Wisconsin
Email: ibenjamin@mcw.edu
https://www.mcw.edu/Cardiovascular-Center/Research-Labs/Ivor-Benjamin-MD-FAHA-FACC.htm
Contact:
MCW Cardiovascular Center
Medical College of Wisconsin
8701 Watertown Plank Rd.
Milwaukee, WI 53226
(414) 955-5611 | Fax (414) 456-6515
Email: cvc@mcw.edu
Website: https://www.mcw.edu/departments/cardiovascular-center-heart
Program Scope and Mission –
This five year T32 program is one of only six post-doctoral T32 training programs on the Milwaukee Medical Regional Campus. The grant provides up to three-years of training for post-doctoral fellows with an MD, PhD, PharmD, or DO degree (two new slots/year). Forty-six basic scientists and translational investigators serve as mentors in a program that is supported by specific research areas of scientific excellence (“Signature Programs”), a highly-integrated collaborative research environment, and access to an extensive research infrastructure.
This three-year training commitment emphasizes critical components designed to launch/sustain research careers: • Individualized development plans (IDPs), • Personalized multidisciplinary mentoring teams, • Training in core competencies, and • Industry/biotechnology or scientific liaison career options for trainees not pursuing a traditional career in academia. Overall, the ultimate goal of this training program is to train the next generation of cardiovascular scientists, including underrepresented minorities, by incorporating broad-based, personalized, supportive, and rigorous training opportunities. Additional support for trainees is provided by a grant from the A. O. Smith Foundation for the Cardiovascular Center’s A. O. Smith Fellowship Scholars Program. This unique program is designed to support talented cardiovascular researchers and physicians in an innovative educational program that aims to provide mentoring, training, research support, and the necessary resources to overcome the barriers that exist to launching and sustaining a successful research career.
Director:
Mark K. Eskandari, MD, F.A.C.S.
The James S. T. Yao, MD, PhD, Professor of Vascular Surgery
Chief and Program Director, Division of Vascular Surgery
Northwestern University
Feinberg School of Medicine
676 N. St. Clair, #650
Chicago, IL 60611
Contact:
Marsha Blunt, VSSTP Program Coordinator
Telephone: (312) 926-7775
Northwestern Email: marsha.blunt@nm.org
https://www.surgery.northwestern.edu/divisions/vascular/research/scientist-training.html
Program Scope and Mission –
The NIH-funded Vascular Surgery Scientist Training Program at Northwestern University is a two-year mentored research training program designed for surgical residents (MD/DO) in general, cardiac, and vascular surgery interested in vascular biology or vascular biomedical engineering careers. Our goal is to provide a seamless multidisciplinary environment in which the trainee may interact with a diverse group of distinguished research faculty. The T32 mechanism provides a stipend, tuition, fees for coursework, travel funds, and health insurance.
The key to this program is an individualized training plan developed by the mentor and trainee. The unique multidisciplinary environment provides trainees with opportunities to work with mentors from different disciplines. The goal of this program is to match the research interest of the trainee to mentors, coursework, seminars, meetings, and a research plan that will collectively provide the experience necessary to launch a successful career as a physician scientist. Trainees may select one of several tracks of study or a combination of tracks:
• Vascular biology with a basic science or translational emphasis,
• Clinical outcomes/health services research
• Biomedical devices in partnership with the Biomedical Engineering Department
• An integrated program designed by the trainee and his/her mentors.
Trainees who select the clinical outcomes/health services research track will pursue the Master of Science in Health Services and Outcomes Research degree program at NU.
Candidates must hold either an MD or DO degree and must have completed at least two years of clinical training prior to enrolling in the program. Candidates must be U.S. citizens, noncitizen nationals, or have been lawfully admitted for permanent residence at the time of appointment. Minorities and women are encouraged to apply. Applicants will submit a written application along with three letters of recommendation.
Director:
Dr. Vidu Garg
Vidu.Garg@nationwidechildrens.org
and
Dr. Peter Mohler
Contact:
Dr. Brenda Lilly
Brenda.Lilly@nationwidechildrens.org
and
Dr. Vidu Garg
Vidu.Garg@nationwidechildrens.org
Program Scope and Mission – A postdoctoral fellow position is available for the T32 Fellowship Program entitled, “Training in Congenital and Acquired Heart Disease.” The program is jointly hosted by the Research Institute at Nationwide Children’s Hospital and the Dorothy M. Davis Heart and Lung Research Institute at The Ohio State University (PIs: Dr. Vidu Garg and Dr. Peter Mohler).
Eligibility requirements are as follows:
• MD, PhD, MD/PhD, DO, DVM, or PharmD, particularly underrepresented minorities, are encouraged to apply. Applicants will receive stipend (at appropriate NIH stipend guidelines), benefits and tuition support.
• Applicant must be a citizen or a non-citizen national of the United States or have been lawfully admitted for permanent residence at the time of appointment.
• Proposed research must be directly related to aspects of congenital or acquired cardiovascular disease and can be basic, translational, clinical or outcomes research.
• 1 year fellowship that is renewed based upon productivity (for a maximum of 2 years).
• Applicants are required to participate in the T32-developed curriculum (i.e. didactic coursework, seminars and/or journal clubs).
• Applications are scored in 3 areas: trainee qualifications, scientific merit and training potential.
Director and Contact:
Jeffery D Molkentin, PHD
Children's Hospital Medical Center-Cincinnati
Office of Sponsored Programs
3333 Burnet Avenue, MLC #7030
Cincinnati, OH 45229
Phone: 513-636-3557
Jeff.molkentin@cchmc.org
https://www.cincinnatichildrens.org/research/divisions/m/mcb/labs/molkentin
Program Scope and Mission – The University of Cincinnati and Children’s Hospital is carrying on a proud tradition of excellence in cardiovascular research and mentorship, which began 35 years ago under Dr Arnold Schwartz as one of the longest training programs in cardiovascular. Our current collective 19 faculty has placed 297 of their past trainees into academics over their careers, 154 of whom have run, or currently run independent research programs. The overall scientific emphasis of our training program will continue to build from a basic platform of cardiovascular physiology, cell biology, biochemistry and pharmacology, but will also incorporate the latest approaches in the post genomic era, as well as incorporating clinical and translational approaches. The cardiovascular environment at Cincinnati Children's and the University of Cincinnati is considered one of the very best in the country, with 19 NIH funded faculty (some 49 NIH grants amongst them as PI status), 166 collaborative papers published in 10 years, and the very latest technologies and approaches with outstanding core support. The leadership consists of the co-PIs Drs. Evangelia Kranias and Jeffery D. Molkentin, both of whom have a long standing track record of working closely together (15 years), as well as having excellent mentorship credentials. The training grant funds 3 pre- and 3 postdoctoral trainees. Predocs are selected by the Internal Advisory Committee from a wide pool arising from departmental graduate programs, while postdoctoral candidates are selected based on being accepted into a mentor's laboratory and then passing the screening process by the Internal Advisory Committee and co-PIs. The training program also has an educational core where both pre-docs and post-docs take elective classes in cardiovascular biology, genetics, statistics, grant writing and ethics in research. More importantly, the cardiovascular training faculty at the University of Cincinnati and Children’s Hospital is one of the largest groups in the nation and they incorporate the very latest technologies in the pursuit of their scientific endeavors. Strengths include generation of transgenic and gene-targeted mice, as well as CRISPR-mediated mouse production, in the pursuit of understanding single gene function in complex cardiovascular diseases. Genetics are also employed and the program also has a strong clinical mentorship track for trainees interested in translational science.
mporary and a defined period (2-year) of mentored advanced training and professional development following completion of a doctoral degree program.
PI/Program Director:
Asrar B. Malik PhD
Contact:
Dr. Asrar B. Malik
Director of Center for Lung and Vascular Biology
University of Illinois College of Medicine
Department of Pharmacology
835 South Wolcott Ave, E403 MSB
Chicago, IL 60612
Phone: 312 996-5672
Email: abmalik@uic.edu
http://mcph.uic.edu/lungt32/
Program Scope and Mission – The NIH-funded UIC vascular biology training program is currently in its 25th year, providing comprehensive and cutting-edge training in vascular biology. Research topics include mechanisms of vascular regeneration, the use of stem cell therapies in vascular disease, the critical role of the vasculature in inflammation and immunity, modeling inherited vascular diseases with induced pluripotent stem cells, vascular biology of cancer, mechanisms of thrombosis and novel therapeutic anti-thrombotics. Our post-docs and PhD students are trained in using state-of-the art technologies such as intravital two-photon microscopy, super-resolution microscopy, protein engineering, high throughput small molecule screening or single cell transcriptomics. The training involves acquiring a range of skills from critical thinking and developing an innovative, testable hypothesis to deploying and utilizing relevant methods and technologies. We also offer opportunities to learn how to best communicate ideas and results through presentations and manuscripts. The success of our trainees is evident from their publication records in top tier journals and their current positions in academia and industry.
We have 40 preceptors participating in the training program who exhibit a breadth of scientific expertise ranging from basic cell biology to translational models of vascular disease. The faculty comprises a cohort of exceptionally talented mentors with a commitment to research training, collaboration, and developing careers of young investigators. These trainees and faculty meet regularly at the weekly vascular biology seminar as well as additional departmental seminars with invited speakers, many of whom are renowned leaders in the field of vascular biology. The program has several defining features that:
· contemporary biomedical research training must be underpinned by collaboration that can be local or international,
· research training is driven by fundamental ideas, and
· solving important scientific problems and research training should be such as to provide a variety of opportunities beyond the training phase.
The research training program provides opportunities for exposure to scientific leaders and role models and the intellectual environment of Chicago. It is our view that nurturing curiosity is a fundamental aspect of research training but that it also involves learning to ask important questions and becoming a well-rounded and humane individual.
Co-Director:
Jan Kitajewski, PhD
Email: kitaj@uic.edu
Co-Director:
Kishore Wary, PhD
Email: kkwary@uic.edu
Contact:
Kamil Czarnowski, MPA
Director of Administrative Operations
Physiology and Biophysics
College of Medicine
University of Illinois at Chicago
835 South Wolcott Ave
Room E-231 MSB
Chicago, IL 60612
Phone: 312-996-3836
Email: kczarn4@uic.edu
Web: https://physiology.uic.edu/training/
Program Scope and Mission – The NIH-funded Vascular Biology, Signaling and Therapeutics (VBST) training program is designed to be interdisciplinary, drawing on institutional expertise in four themes: Angiogenesis & Regeneration, Vascular Signaling, Neurovascular Biology and Vascular Therapeutics. VBST is made up of twenty-six (26) mentors, of which nine (9) are physician-scientists. This training program utilizes expertise within and interactions between the themes to train predoctoral and postdoctoral applicants in an integrative fashion.
VBST strives to meet an imperative need to train exceptionally talented and diverse scientists engaged in interdisciplinary vascular research with translational potential. The program’s aims are to assure that trainees understand the human vascular system, and are thereby poised to advance translational opportunities, reduce vascular disease, and bridge the current gaps in knowledge between discovery research, drug development and therapy.
Director and Contact:
Dawood Darbar, MBChB, MD
Email: darbar@uic.edu
Program Scope and Mission – Project Summary Cardiovascular disease (CVD) remains a major cause for significant morbidity and mortality in the U.S. especially in ethnic minorities with their high burden of risk factors. Personalized medicine is a rapidly growing field of healthcare whereby an individual's unique genomic, environmental and clinical background is analyzed to ascertain susceptibility to disease, predict their clinical course and tailor specific therapies. Despite recent advances in CV genomics, our inability to target therapy to underlying mechanisms in individual patients, the failure to translate these scientific discoveries to the bedside care of patients and barriers to the incorporation of ethnic minorities in translational CV research have limited our ability to fulfill the promise of personalized medicine. Furthermore, traditional training programs are no longer able to provide trainees with the requisite skills needed to implement the personalized medicine revolution underway. Thereby, major goals of the Training Program in Personalized Cardiovascular Medicine (TPIPCVM) are to equip trainees to become leaders in CV Genomics and be trained in molecular, cellular, disease and whole animal modeling and clinical and translational approaches to CVD so that this new knowledge can be translated into best evidence-based personalized CV care. We will recruit highly talented and motivated pre- and post-doctoral trainees and provide them with the highest caliber training in CV genomics stemming from existing strengths of our faculty in the Division of Cardiology and our partners at UIC. The 3 Research Focus Groups: 1) Cardiac arrhythmias; 2) Ischemic and non-ischemic cardiomyopathy; and CVD-related metabolic syndrome are highly interrelated with each other and directly linked with the central theme of Personalized CV Genomics. The overarching goal of the TPIPCVM is to train the next generation of CV investigators to create new knowledge and implement into best evidence-based personalized medicine. The TPIPCVM mentors are highly successful physician-scientists/scientists with a proven record of research, mentoring and collaboration who offer superb inter- and multi- disciplinary training opportunities. Major strengths of this training program include: exposure of trainees to an integrated basic science molecular, cellular, and whole patient approach to identify the underlying mechanisms of CVD; the track record of the faculty and their common research interest in Personalized CV Genomics; dedicated training in personalized CV medicine; and the potential to implement scientific discoveries to a diverse and under-represented population of patients cared for at UIC Medical Center. The TPIPCVM sets out to train 2 pre-doctoral and 2 post-doctoral students annually. Collectively, this Training Program offers a unique training experience and fulfills an urgent need for training in personalized CV medicine.
Public Health Relevance
The Training Program In Personalized Cardiovascular Medicine (TPIPCVM) provides support for the training of basic and physician-scientists before and after their doctoral degrees. The central theme of the training program is cardiovascular genomics with a focus on abnormal heart rhythms (arrhythmias), weakened heart muscle (cardiomyopathies) and heart disease related the being overweight (metabolic syndrome) and how we can translate these discoveries to the bedside care of patients. The program will prepare future researchers for the unique challenges associated with treating patients with heart disease in an individualized manner.
Director and Contact:
Martha L. Daviglus, M.D., Ph.D.
Adjunct Professor of Preventive Medicine and Medicine
Executive Director, Institute for Minority Health and Research
Associate Vice Chancellor for Research
Email: daviglus@uic.edu
Phone: 312-413-0739
http://chicago.medicine.uic.edu/research/research-in-chicago/institute-for-minority-health-research/administrative-staff/name/martha-daviglus/
Website: http://chicago.medicine.uic.edu/departments/academic-departments/medicine/research/research-training-programs/
Program Scope and Mission – This Training Program is designed to prepare the next generation of scientists to conduct research in the epidemiology and prevention of cardiovascular disease (CVD) and related chronic diseases in minority populations. Despite decades of research progress, the burden of CVD and related chronic diseases in the United States remains high. Moreover, there are persistent race/ethnic disparities in CVD and other chronic disease outcomes. The goal of this program is to generate a talented and well-trained group of pre- and post-doctoral (MD and PhD) researchers to improve understanding of the etiology and prevention of CVD and related chronic conditions in minority populations and to alleviate race/ethnic disparities in CVD and related chronic disease outcomes.
Director:
Francois M. Abboud, M.D.
Edith King Pearson Chair of Cardiovascular Research
Associate Vice President for Research
Chair Emeritus, Department of Internal Medicine
Founding Director, Francois M. Abboud Cardiovascular Research Center
Professor of Internal Medicine – Cardiovascular Medicine
Professor of Molecular Physiology and Biophysics
Email: Francois-abboud@uiowa.edu
https://medicine.uiowa.edu/internalmedicine/profile/francois-abboud
Contact:
Loretta Bassler
Email: Loretta-bassler@uiowa.edu
Website: https://medicine.uiowa.edu/cardiovascular/research/abboud-cardiovascular-research-center-t-32
Program Scope and Mission – The discovery of the causes of cardiovascular disease and their prevention; the care of the suffering patients and their cure, requires dedicated physicians and scientists to devote their lifelong work to a health mission without which a civilized society would not survive. Such individuals require years of training in medical science beyond their professional degree under the tutelage and mentoring of established senior medical investigators/teachers working in an environment with exceptional intellectual, technical, and physical resources. At the University of Iowa Cardiovascular Research Center, we have provided a world-renowned training center since 1975, have graduated hundreds of scientists, many of whom are national leaders throughout the USA, and aim to continue to do so for future generations with the renewal of federal support that we are applying for and hope to attain.
Contact:
Daniel Michele, PhD
Professor, Departments of Molecular and Integrative Physiology and Internal Medicine
University of Michigan
North Campus Research Complex
2800 Plymouth Road, Bldg 26, Room 207S
Ann Arbor, MI 48109-2800
Email: dmichele@umich.edu
Website: https://sites.google.com/umich.edu/cvre-t32/home
Program Scope and Mission – Cardiac and vascular diseases remain the leading causes of death worldwide, and the demand for a diversely trained PhD workforce to develop new therapies is expanding. The program goal is to address this deficit in the PhD workforce by teaching the next generation of cardiovascular PhD scientists and engineers how to develop and translate basic research towards applications in clinical medicine. This Predoctoral Training Program includes training on how to conduct preclinical translational research, improve understanding of steps of developing therapies from bench to bedside, and experiential learning in research entrepreneurship. All training is conducted at state of the art facilities of the Frankel Cardiovascular Center laboratories alongside world leading research teams in basic and translational research, clinical research, health services and outcomes research, and multidisciplinary programs.
The Program Features Include:
Basic Cardiovascular Research Training
- Selection of Research Training Mentor & Project and Perform Laboratory Research
- Selection of Clinical Advisor for your Project
- Frontiers in Cardiovascular Sciences Seminar Series
- Research Responsibility and Ethics Training
Training in Pre-Clinical Translational Research
- Pre-clinical Cardiovascular Models, Preclinical Testing and Phenotyping
- Translational Cardiovascular Research Seminars
Training in Research Entrepreneurship
- Research Entrepreneurship Bootcamp
- Entrepreneurship Course
- Experiential Learning in Project Design, Management and Team Science
Fellows are encouraged to explore a variety of additional enrichment activities to supplement the requirements of the training grant.
Directors:
Samuel Dudley, MD, PhD
and
Peter Crawford, MD, PhD
Contact:
Elizabeth Gorka
Email: egoldsmi@umn.edu
Program Scope and Mission – This Training Program in Cardiovascular Innovation is designed to teach the scientific and technical skills necessary to develop a novel idea and carry this idea through to proof-of-concept in man. The training program takes unique advantage of the strengths of the Lillehei Heart Institute (LHI), the University of Minnesota Cardiovascular Division, the wider community of translational medicine and entrepreneurship at the University of Minnesota, and the Twin Cities biotech, pharma, and device industries. This application trains basic and clinical scientists in an interdisciplinary environment with the goal of giving them the insight and tools to be able to successfully carry an idea from conception to implementation in man. Therefore, the major goal of this new Training Program is to provide an interdisciplinary research and training environment wherein trainees will be exposed to the continuum of technological development from conceptual idea to testing at the basic, small animal, large animal, and human levels. Trainees will be advantaged by community strengths in basic, translational, and clinical science, training in cardiovascular innovation and entrepreneurship, and industry interactions and mentorship. The combination of scientific and entrepreneurship training is the central innovative feature of this application.
Director:
Dr. Anjon Audhya
Molecular and Cellular Pharmacology
School of Medicine and Public Health
5214a Biochemistry
420 Henry Mall
Madison, WI 53706
Phone: (608) 262-3761
Email: audhya@wisc.edu
Contact:
Kristin Cooper, MS
Program Coordinator
Molecular and Cellular Pharmacology
University of Wisconsin-Madison
Mail: Room 1005, 1111 Highland Ave
Office: L5/175
Madison, WI 53705
Phone: (608) 262-9826
Email: kgcooper@wisc.edu
http://molpharm.wisc.edu/
Program Scope and Mission – Pharmacology is the knowledge of the biochemical and physiological actions of drugs, which act on cellular signaling pathways. The molecular basis of cellular signaling and its control by various drugs is a major aspect of modern pharmacology and this aspect is emphasized in the Molecular and Cellular Pharmacology Training Program. The majority of signal transduction pathways still await discovery or at least a thorough molecular characterization. Members of our program employ the whole spectrum of modern biochemical, cell and molecular biological, physiological, and pharmacological methods in a basic research-oriented scientific environment to unravel the many unsolved mysteries underlying cellular regulation and signaling. Certain research initiatives have a translational component, with the goal of applying basic discoveries to developing new therapeutic modalities.
Our program brings together an outstanding group of over 70 dedicated trainers with a focus on cellular signal transduction. Graduates of the program will be well prepared for a career in basic biomedical sciences in academia, industry, and more. We provide a unique training experience for young scientists who want to elucidate basic principles of cellular signal pathways. Detailed knowledge of these pathways is the most important prerequisite for the discovery of new drugs and the treatment of diseases. The members of the Molecular and Cellular Pharmacology Training Program invite you to examine the educational and research opportunities described on our website, and to consider joining this unique and exciting graduate program.
Director:
Jian-Ping Jin, M.D., Ph.D.
Professor & William D. Traitel Endowed Chair
Wayne state University School of Medicine
Department of Physiology
Email: jjin@med.wayne.edu
Contact:
Christine R. Cupps
Program Administrator
Detroit Cardiovascular Training Program
Wayne State University
Department of Physiology
5278 Scott Hall
540 E. Canfield
Detroit, MI 48201
Phone: 313-577-4639
Email: ccupps@med.wayne.edu
Website: http://physiology.med.wayne.edu/dctp
Program Scope and Mission – Cardiovascular disease is a leading cause of mortality in the United States. Understanding the physiology and pathology of the heart and circulation is the foundation for improving the treatment and prevention of cardiovascular diseases. The Detroit Cardiovascular Training Program (DCTP) was the first NIH-supported predoctoral training program in the region to provide research training for PhD graduate students in integrative and translational cardiovascular sciences. This training effort is contributing to the education of a new generation of scientists who will not only pursue cardiovascular research to improve health care, but also strengthen our economic base by innovations that will be translated to medical practice.
The DCTP has assembled an leading group of researchers from multiple departments such has Physiology, Biomedical Engineering, and Pharmaceutical Sciences, who provide expertise and research opportunities to trainees that range from molecular, cellular and organ levels to clinic research. In addition, Wayne State University has an outstanding track record of providing extensive training in the cardiovascular sciences and an exceptional record in the training of minority students in the Detroit metropolitan area, contributing a major role in research education in the region.
Simply send a description of your program to sharon@navbo.org. Include contact information and links to your web site.
West
Co-Directors:
Eduardo Marbán, M.D., Ph.D.
Mark Siegel Family Foundation Distinguished Chair and Director of the Heart Institute
Director, Cedars-Sinai Smidt Heart Institute
Professor of Medicine and Physiology
http://bio.csmc.edu/view/5280/Eduardo-Marban.aspx
Joshua I. Goldhaber, M.D.
Dorothy and E. Phillip Lyon Chair in Laser Research
Director, Basic Research Programs
Director, Cardiology Fellowship Program
Associate Director, Cardiac Intensive Care Unit
Director, Division of Applied Cell Biology & Physiology
Professor of Medicine
http://bio.csmc.edu/view/4671/Joshua-I-Goldhaber.aspx
Contact:
Dana Kramer
Email: cshi.training@cshs.org
Website: https://www.cedars-sinai.edu/Education/Graduate-Research-Education/Training/Heart-Institute-NIH-T32-Funded-Training-Program-for-Postdoctoral-Research.aspx
Program Scope and Mission – The objective of The Cedars-Sinai Smidt Heart Institute Institutional Training Program is to provide postdoctoral fellows with the necessary skills to develop independent and productive academic careers in cardiovascular science. We seek to ensure that all our trainees, be they PhDs, MDs, MD/PhDs or equivalent, develop an in-depth knowledge of the basic science underpinning clinically relevant problems in cardiovascular medicine, as well as a comprehensive understanding of rigorous study design, appropriate methodology and expert technical execution of basic and clinical studies. This not only provides clinical investigators with the skills they need to properly test hypotheses generated at the basic science level, but also informs basic scientists about the clinical aspects of disease in order to stimulate clinically relevant state-of-the-art investigations in the laboratory.
Our training program’s areas of research focus include Cardiac Biology, Arrhythmias, Vascular Biology and Atherosclerosis, Regenerative Medicine, Transplant Immunology, Cardiovascular Imaging, Women’s Health, Community Health, Implementation Science, Precision Medicine and Genetics. The Training Program takes full advantage of the unique strengths of Cedars-Sinai Medical Center (CSMC), the largest private teaching hospital west of the Mississippi, which has a longstanding commitment to translational research and to serving the local community. The Cedar Sinai Heart Institute (CSHI) houses the largest adult heart transplant program in the world, performed an NIH-funded first-in-human trial of cardiac-derived stem cell therapy, and has attracted many NIH-funded basic and translational investigators. Some of these share joint appointments in other CSMC units, which include the Regenerative Medicine Institute, Biomedical Imaging Research Institute, and the Departments of Biomedical Sciences, Medicine, and Pathology. Trainees receive an intensive research experience in a focused area of investigation, augmented by a formal curriculum that includes both basic and clinical seminars, instruction in grant and manuscript writing, public speaking, biostatistics and ethics. Several courses are provided by the Department of Biomedical Sciences, the CSMC Clinical Scholars Program, and a multi-campus NIH CTSA-supported Center for Translational Science Institute (CTSI, includes CSMC, UCLA, Harbor-UCLA, and Charles Drew University). The CTSI provides our trainees with privileged access to project seed funds, additional courses in clinical research design, and tools for conducting the entire range of studies from bench to bedside to community. In summary, we have designed a program that provides in-depth training in critical areas of cardiovascular science within an environment that champions translational research and clinical excellence.
Contact:
Nabil J. Alkayed, MD, PhD
James Metcalfe Chair of Cardiovascular Medicine
Professor and Director of Research, Knight Cardiovascular Institute
Oregon Health & Science University
3181 S.W. Sam Jackson Park Road, Portland, Oregon 97239
Mail Code: UHN-2 ; Phone: 503.418.5502
Fax: 503.494.3092
alkayedn@ohsu.edu
Program Scope and Mission – http://www.navbo.info/OHSU2017-18.pdf.
Director:
Christopher Gardner, PhD
Contact:
Alana Koehler, Fellowship Coordinator
Administrative Associate for Christopher Gardner, PhD
Stanford Prevention Research Center
1265 Welch Road, X3C06
Stanford, CA 94305-5411
Voice 650 723 7822
Fax 650 725 6247
Email: alana.koehler@stanford.edu
Program Scope and Mission Postdoctoral Research Fellowship in Chronic Disease Prevention and Control. The Stanford Prevention Research Center, an interdisciplinary research program on the prevention of chronic disease, is seeking MD and PhD applicants for postdoctoral research fellowships for the academic year 2018-2019. Fellows gain direct research experience in cardiovascular disease prevention, community and health psychology, behavioral medicine, intervention methods, clinical epidemiology, research design, and biostatistics.
See also the website for additional details http://prevention.stanford.edu/education/fellowship/training.html
Contact:
Joseph Wu, MD, PhD
Stanford University School of Medicine
ProfessorDirector, Stanford Cardiovascular Institute
Simon H. Stertzer, MD Professor of Medicine & Radiology
Lorry I. Lokey Stem Cell Research Building
265 Campus Drive, Rm G1120B
Stanford, CA 94305-5454
Ph: 650-736-2246
Fax: 650-736-0234
Email: joewu@stanford.edu
CVI Website: http://med.stanford.edu/cvi.html
Program Scope and Mission – The Multi-Disciplinary Training Program in Cardiovascular Imaging at Stanford is funded by the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health. The program is designed to train the next generation of CV imaging investigators by exposing them to three complementary areas – clinical, engineering, and molecular imaging. With the impact of cardiovascular disease on US and world health and the rapid advances in imaging technologies and cardiovascular biology, it is critical that fellows be provided a broad, multi-disciplinary, and collaborative training program to foster their ability to translate CV imaging research into clinical application. Mentors from the Schools of Medicine and Engineering, including Cardiovascular Medicine, Radiology, Molecular Imaging, Electrical Engineering, and Bioengineering are available. For more details: http://med.stanford.edu/cvi/education/cardiovascular-imaging-t32.html
Director:
Reza Ardehali, M.D., Ph.D.
Associate Professor of Medicine
Associate Chief of Cardiology, Regenerative Medicine
Advanced Heart Failure, Mechanical Circulatory Support and Transplantation
Division of Cardiology
Broad Stem Cell Research Center
UCLA School of Medicine
675 Charles E. Young Drive S. Rm 3780
Los Angeles, CA 90095
Email: rardehali@mednet.ucla.edu
Website: https://vbtg.mcdb.ucla.edu/
Contact:
Nikki Jobanputra
Sr. Admin Analyst
Division of Cardiology
Broad Stem Cell Research Center
UCLA School of Medicine
Phone: 310-825-2554
Email: NJobanputra@mednet.ucla.edu
Program Scope and Mission - The main objective of the Vascular Biology Training Program is to develop the next generation of cardiovascular biologists. The program places a strong emphasis on creativity, networking and self-motivation to develop independent scientists who will make significant contributions to biomedical research and be an asset to the institutions and communities they serve.
To achieve these goals, we have developed a strong mentorship approach, novel didactic components and incorporated high exposure to medicine. UCLA houses a tremendous resource of interdisciplinary groups whose research focuses in vascular biology. The group includes 27 laboratories that currently offer training to 124 graduate students and postdoctoral fellows. It is this community that constitutes the pillars of a unique training program for the next generation of investigators in this area of research. The Program is funded by a grant from the NHLBI that supports pre- and post-doctoral trainees for three and two years respectively. The program also features a highly interactive seminar series with outside speakers and several seminar venues for discussion of science by trainees and UCLA investigators. We invite you to drive through the website and get to learn more about our program and recent accomplishments.
Director:
Matthew A. Allison, MD, MPH, FAHA
University of California San Diego
Professor and Interim Chief
Division of Preventive Medicine
Department of Family Medicine and Public Health
9500 Gilman Drive, Mailcode 0965
La Jolla, CA 92093-0965
Phone: 858-642-3289
Fax: 858-822-7662
mallison@ucsd.edu
Contact:
Nova Barkley, T32 coordinator
9500 Gillman Drive, MC 0607
La Jolla, CA 92093-0607
nsbarkley@ucsd.edu
Program Scope and Mission – http://cvdepit32.ucsd.edu.
Director and Contact:
Andrew D. McCulloch, Ph.D.
UC San Diego
Department of Bioengineering
9500 Gilman Ave. MC0412
La Jolla, CA 92093-0412
Office: 858-534-2547
Fax: 858-534-5722
amcculloch@ucsd.edu
Program Scope and Mission – The aim of this program is to train pre-doctoral bioengineering graduate students to apply quantitative bioengineering approaches to study integrative cardiac, vascular and blood physiology and pathophysiology and to work with physicians on developing novel technologies for therapy and diagnosis of cardiovascular diseases. Trainees learn how to conduct interdisciplinary research by integrating: (a) the engineering and biomedical sciences; (b) across physical scales of biological structure from genes and molecules to tissues and organ-systems; (c) across interacting physiological systems and subsystems; and (d) basic research with technology innovation for clinical applications. Our goal is to train the next generation of bioengineering scientists to be leaders in innovative cardiovascular research and technology development to advance healthcare delivery and improve health outcomes. The program is especially well known for its leadership in systems biology, regenerative medicine and multi-scale bioengineering. Graduates have gone on to become leaders in research, industry and academia including department chairs of top programs.
Director:
Judith Hellman, MD
Contact:
Claire Harmon
Research Administration Manager
Department of Anesthesia & Perioperative Care
3333 California Street, Suite 290
San Francisco, CA 94118
Phone: 415-476-4762
Fax: 415-514-0500
Email: claire.harmon@ucsf.edu
Website: https://anesthesia.ucsf.edu/nih-t32-postdoctoral-research-fellowship
Program Scope and Mission The primary goal of the program is to provide rigorous training in the fundamentals and techniques of conducting research in areas of concern to clinical anesthesiology and the larger practice of medicine. The Vascular Biology and Bioengineering Track hosts faculty mentors from the Departments of Anesthesia, Biochemistry and Biophysics, Bioengineering, Cellular and Molecular Pharmacology, Medicine, Neurosurgery, Radiology & Biomedical Imaging, and Surgery. Among the broad range of topics studied are AVMs, stroke, vascular aneurysms, drug delivery across the blood brain barrier, spinal cord injury and repair, G-protein coupled receptors, PPARs, thrombosis, novel bioengineered therapeutic antibody development and biomedical imaging. Additional program tracks include Critical Care; Genomics, Outcomes Research and Bioinformatics; and Neuroscience, Pain and Addiction. Funded by the NIH/NIGMS since 1995, the T32 program supports 2 to 3-year trainee appointments, dependent on sufficient trainee progress. Applicants should be MD or MD/PhD scientists, and must be United States citizens, permanent residents or non-citizen nationals. UCSF has an exceptional commitment to excellence and diversity. We welcome all qualified applications and particularly encourage applications from members of underrepresented groups in the sciences, including underrepresented minorities, veterans, and individuals with disabilities. UCSF offers reasonable accommodations for qualified individuals with disabilities. If you are a person with a disability who would like to discuss potential accommodations or engage in a confidential conversation, please contact Disability Management Services at 415-476-2621. Applications are accepted on a continuous basis. For more information and application instructions, contact Claire Harmon at the address above, or visit the program website.
Contact:
Thomas C. Resta, PhD
Professor and CRTP Director
Vascular Physiology Group
Dept. of Cell Biology and Physiology
MSC08 4750
1 University of New Mexico
Albuquerque, NM 87131-0001
Phone: 505-272-8822
Email: tresta@salud.unm.edu
Home Page: http://cbp.unm.edu/faculty-profiles/resta.html
Website: https://hsc.unm.edu/research/brep/graduate/bsgp/crtp.html
Program Scope and Mission – The Cardiovascular Research Training Program (CRTP) at the University of New Mexico (UNM) Health Sciences Center (HSC) is funded by a T32 grant from the NIH National Heart Lung and Blood Institute (NHLBI). The goal of the CRTP is to provide exceptional pre- and post-doctoral trainees a broad, multidisciplinary background in cardiovascular and pulmonary research with integration between basic and clinical sciences. The CRTP partners with the interdisciplinary Biomedical Sciences Graduate Program (BSGP; http://hsc.unm.edu/research/BREP/graduate/bsgp/index.html) at the UNM HSC. This non-departmental program provides training for PhD students in biomedical sciences in the first year followed by in-depth training in the chosen discipline in subsequent years. A training program with a concentration in cardiovascular physiology is available for all predoctoral CRTP trainees in the BSGP. The CRTP T32 provides an NIH level stipend, and allowances for tuition and fees, health insurance, training-related expenses, and travel to scientific meetings. Appointments are 2-3 years for predoctoral students and 2 years for postdoctoral trainees, with subsequent support provided by individual training fellowships or mentored career awards. Applications are restricted to U.S. citizens or permanent residents. For more information and program application instructions, please contact the CRTP Program Director, Dr. Thomas Resta, at the address below.
Simply send a description of your program to sharon@navbo.org. Include contact information and links to your web site.